26662311 |
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
Sedivcova, M,
Holubec, L,
Bartouskova, M,
Matejka, VM,
Kulhankova, J,
Liska, V,
Topolcan, O,
Finek, J,
Mohelnikova-Duchonova, B,
Buchler, T,
Melichar, B,
Bortlicek, Z,
Fiala, O
|
Tumour Biol. |
2016 |
29199977 |
Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras
Kennedy, MA,
Xu, S,
Long, BN,
Boris, GH,
Ni, S,
Chen, A
|
Acta Crystallogr D Struct Biol |
2017 |
30738221 |
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
Biemar, J,
Garcia, S,
Milia, J,
Souquet-Bressand, M,
Ouafik, L,
Chaleat, S,
Grangeon, M,
Nanni, I,
Jeanson, A,
Mazieres, J,
Tomasini, P,
Boucekine, M,
Greillier, L,
Khobta, N,
Mhanna, L,
Mascaux, C,
Barlesi, F,
Brandone, N
|
J Thorac Oncol |
2019 |